Making quality-of-life results more meaningful for clinicians.
King
Madeleine T
MT
Centre for Health Economics, Research & Evaluation, University of Technology, Sydney, NSW 2043, Australia. Madeleine.King@chere.uts.edu.au
Fayers
Peter M
PM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006304:Health Status; D006801:Humans; D007372:Interferons / Q000008:administration & dosage; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D007372:Interferons; D008558:Melphalan; D011241:Prednisone